ipique
rotterdam biologics b.v. - bevacizumab - degenerarea maculară umedă - oftalmologice - treatment of neovascular (wet) age-related macular degeneration (amd).
vegzelma 25 mg/ml
millmount healthcare ltd. - irlanda - bevacizumabum - conc. pt. sol. perf. - 25mg/ml - anticorpi monoclonali inhibitori vegf/vegfr
alymsys 25 mg/ml
gh genhelix s.a. - spania - bevacizumabum - conc. pt. sol. perf. - 25mg/ml - anticorpi monoclonali si conjugati inhibitori vegf/vegfr
mvasi 25mg/ml
amgen europe bv - olanda - bevacizumabum - conc. pt. sol. perf. - 25mg/ml - anticorpi monoclonali si conjugati inhibitori vegf/vegfr
oyavas 25 mg/ml
gh genhelix s.a - spania - bevacizumabum - conc. pt. sol. perf. - 25mg/ml - anticorpi monoclonali si conjugati inhibitori vegf/vegfr
zirabev 25mg/ml
pfizer ireland pharmaceuticals - irlanda - bevacizumabum - conc. pt. sol. perf. - 25mg/ml - anticorpi monoclonali si conjugati inhibitori vegf/vegfr
cablivi 10 mg
ablynx nv - belgia - caplacizumabum - pulb.+solv. pt. sol. inj. - 10mg - antitrombotice alte medicamente antitrombotice
tysabri 150mg
biogen (denmark) manufacturing aps - danemarca - natalizumabum - sol. inj. in seringa preumpluta - 150mg - imunosupresoare imunosupresoare selective
tysabri 300mg
biogen (denmark) manufacturing aps - danemarca - natalizumabum - conc. pt. sol. perf. - 20mg/ml - imunosupresoare imunosupresoare selective
abevmy 100 25 mg/ml concentrat pentru soluţie perfuzabilă
biosimilar newco. limited (a biocon biologics company) - bevacizumabum - concentrat pentru soluţie perfuzabilă - 25 mg/ml